Background. Implantable left ventricular assist device (LVAD) insertion complicated by early
right ventricular (RV) failure has a poor prognosis and is generally unpredictable. Methods. …

Background: Implantable left ventricular assist devices are common as a bridge to transplantation
but are just reaching their goal as an alternative to transplantation. Methods: From …

Background The HeartMate left ventricular assist device has been successfully used as a
bridge to cardiac transplantation. Because many patients exhibit marked clinical improvement …

Background. Patients bridged to transplantation (TX) with the implantable left ventricular assist
device (LVAD) may be at increased risk for the development of panel-reactive antibodies (…

Objective: We sought to determine the role of partial left ventriculectomy in patients with
dilated cardiomyopathy. Methods: Since May 1996 we have performed partial left …

Background Although use of long-term implantable left ventricular assist devices (LVAD) is
becoming more popular, further reduction of the mortality rate accompanying device insertion …

Long-term support on the implantable left ventricular assist device (LVAD) produces structural
changes in the recipient's heart. To assess the possibility of heart “recovery” we reviewed …

The purpose of this report is to analyze long-term clinical outcomes of patients exposed to
plerixafor plus granulocyte colony-stimulating factor (G-CSF) for stem cell mobilization. This …

BACKGROUND.: Infection in implantable left ventricular assist device (LVAD) patients is
common and has serious implications regarding permanent use of the LVAD. METHODS.: Thirty…

To evaluate hemodynamic effectiveness and physiologic changes on the HeartMate 1000
IP left ventricular assist device (Thermo Cardiosystems, Inc., Woburn, Mass.), we studied 25 …